大麻素和β-糖:慢性炎症性疼痛
Mohammed Alnoud1, Mohammad S Hussain2, Jose Rios1
1Institute of Neuroscience and Department of Neuro-behavioral Health, University of Texas Rio Grande Valley, School of Medicine, Biomedical building, McAllen, TX 78504, United States.
Pharmacological research
|October 21, 2025
概括
Cannabidiol (CBD) 和Beta-Caryophyllene (BCP) 的组合提供了协同作用的止痛药和抗抑郁药. 这种植物性大麻素配对有效降低神经炎症,这表明了治疗慢性疼痛和同时存在的抑郁症的新方法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 疼痛管理 疼痛管理
背景情况:
- 慢性疼痛和抑郁症经常同时发生,这给管理带来了重大挑战.
- 目前治疗慢性疼痛和抑郁症的方法通常是分开的,缺乏一致的有效性.
- 综合治疗策略是这些普遍疾病的公共卫生优先事项.
研究的目的:
- 为了研究植物性大麻素 (CBD) 和β-Caryophyllene (BCP) 对慢性疼痛的联合疗效.
- 评估CBD和BCP组合的潜在抗抑郁作用.
- 探索组合治疗的潜在作用机制.
主要方法:
- 在小鼠中使用了由完整的弗伦德辅助剂 (CFA) 诱导的慢性炎症性疼痛模型.
- 进行了一系列测试,以评估类似疼痛和类似抑郁的行为.
- 采用蛋白质组学和免疫组织化学 (IHC) 来分析分子变化和神经炎症.
主要成果:
- 在CFA模型中,CBD和BCP的组合显示出协同作用的疼痛缓解.
- 用CBD和BCP组合治疗的小鼠表现出显著的抗抑郁药物特性.
- IHC和蛋白质组学表明,这种组合比单个成分更有效地减少了CFA诱导的神经炎症.
结论:
- 在慢性炎症性疼痛模型中,CBD和BCP的组合提供了协同作用的疼痛缓解和抗抑郁作用.
- CBD和BCP的抗炎作用可能有助于它们的联合治疗效益.
- 这种植物性大麻素组合是治疗慢性疼痛和相关抑郁症的有希望的治疗候选者.
相关概念视频
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
666
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
666
01:25Analgesia and Pain Management
1.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
772
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
772
01:44Nociception
33.0K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
33.0K
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
908
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
908
01:29Chronic Pancreatitis II: Collaborative Care
311
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
311